Can a medicine be FDA approved for one condition and end up also being a breakthrough in another? The surprising answer is YES, and Dr. Jim outlines key points about one of the latest diabetes treatments called Mounjaro (tirzepatide). This novel drug for type 2 diabetes may become the hottest weight loss medicine in 2023.You’ll get 6 top tips covering everything from Standards of care in diabetes, clinical trials and even the role of natural medicines in helping lower blood sugar.